SEK 0.01
(16.52%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 21.4 Million SEK | -15.37% |
2022 | 25.29 Million SEK | -14.77% |
2021 | 29.67 Million SEK | -28.04% |
2020 | 41.24 Million SEK | 34.29% |
2019 | 30.71 Million SEK | -37.43% |
2018 | 49.08 Million SEK | 339.28% |
2017 | 11.17 Million SEK | 73.87% |
2016 | 6.42 Million SEK | 83.86% |
2015 | 3.49 Million SEK | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 21.81 Million SEK | 1.92% |
2024 Q2 | 17.62 Million SEK | -19.24% |
2023 Q3 | 23.61 Million SEK | -47.94% |
2023 Q1 | 21.99 Million SEK | -13.03% |
2023 Q2 | 45.35 Million SEK | 106.18% |
2023 FY | 21.4 Million SEK | -15.37% |
2023 Q4 | 21.4 Million SEK | -9.34% |
2022 Q3 | 24.85 Million SEK | -23.94% |
2022 Q2 | 32.67 Million SEK | 41.36% |
2022 FY | 25.29 Million SEK | -14.77% |
2022 Q4 | 25.29 Million SEK | 1.78% |
2022 Q1 | 23.11 Million SEK | -22.11% |
2021 Q3 | 24.97 Million SEK | -14.17% |
2021 FY | 29.67 Million SEK | -28.04% |
2021 Q4 | 29.67 Million SEK | 18.83% |
2021 Q2 | 29.09 Million SEK | -12.62% |
2021 Q1 | 33.29 Million SEK | -19.27% |
2020 FY | 41.24 Million SEK | 34.29% |
2020 Q1 | 25.34 Million SEK | -17.47% |
2020 Q2 | 25.12 Million SEK | -0.86% |
2020 Q3 | 20.06 Million SEK | -20.14% |
2020 Q4 | 41.24 Million SEK | 105.51% |
2019 Q4 | 30.71 Million SEK | -13.24% |
2019 FY | 30.71 Million SEK | -37.43% |
2019 Q3 | 35.39 Million SEK | -9.24% |
2019 Q2 | 39 Million SEK | -11.7% |
2019 Q1 | 44.17 Million SEK | -10.0% |
2018 Q1 | - SEK | -100.0% |
2018 Q4 | 49.08 Million SEK | 0.0% |
2018 FY | 49.08 Million SEK | 339.28% |
2018 Q2 | 6 Million SEK | 0.0% |
2017 Q2 | 4.46 Million SEK | 0.0% |
2017 FY | 11.17 Million SEK | 73.87% |
2017 Q4 | 11.17 Million SEK | 0.01% |
2017 Q3 | 11.17 Million SEK | 150.0% |
2017 Q1 | 4.46 Million SEK | 0.0% |
2016 FY | 6.42 Million SEK | 83.86% |
2015 FY | 3.49 Million SEK | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
AddLife AB (publ) | 12.74 Billion SEK | 99.832% |
Biotage AB (publ) | 4.93 Billion SEK | 99.566% |
Bonesupport Holding AB (publ) | 688.81 Million SEK | 96.892% |
Doxa AB (publ) | 3.75 Billion SEK | 99.43% |
Elekta AB (publ) | 31.41 Billion SEK | 99.932% |
iZafe Group AB (publ) | 34.61 Million SEK | 38.154% |
Ortivus AB (publ) | 72.7 Million SEK | 70.556% |
Ortivus AB (publ) | 72.7 Million SEK | 70.556% |
Q-linea AB (publ) | 231.97 Million SEK | 90.772% |
Synsam AB (publ) | 8.03 Billion SEK | 99.734% |